conditions affecting the heart muscle (cardiomyopathies and myocarditis). Around 920,000 people in the UK were living with heart failure in 2018 with an estimated 200,000 new diagnoses each year.
Two artificial intelligence (AI) algorithms designed to diagnose people with heart rhythm abnormalities have been approved by the FDA for use with Medtronic's LINQ II cardiac monitor. The AccuRhythm ...
The diagnostics advisory committee looked at evidence on algorithm-based remote monitoring of heart failure in people with cardiac implantable electronic devices (CIEDs). Evidence was considered from ...
Two artificial intelligence (AI) algorithms designed to diagnose people with heart rhythm abnormalities have been approved by the FDA for use with Medtronic's LINQ II cardiac monitor. The AccuRhythm ...